血管造影カテーテル市場：製品別、用途別、地域別、2024年～2031年

血管造影カテーテル市場の評価、2024年～2031年

血管造影カテーテル市場は、いくつかの要因により需要が急増しています。主に、冠動脈疾患や脳卒中などの心血管疾患の有病率の増加により、診断および介入処置の必要性が高まっています。これらのカテーテルは血管を可視化し、血管形成術やステント留置術のような低侵襲治療を行う上で重要な役割を果たしています。市場規模は2024年に13億7,000万米ドルを突破し、2031年には約24億2,000万米ドルに達します。

カテーテル技術の進歩により、材料の改良、細径化、画像処理機能の強化など、より効果的で低侵襲なカテーテルが実現し、需要をさらに押し上げています。心血管疾患に罹患しやすい高齢化人口の増加が市場拡大に寄与しています。費用対効果が高く効率的な血管造影カテーテルに対する需要の高まりにより、市場は2024年から2031年にかけてCAGR 7.38%で成長する見込みです。

血管造影カテーテル市場定義/概要

血管造影カテーテルは、血管造影手術中にX線画像で見えるようにするため、血液動脈に造影剤を注入する特殊な医療機器です。これらのカテーテルは、心臓の動脈、静脈、心室の構造と機能を確認するのに役立ち、臨床医が閉塞、動脈瘤、先天性異常を含む広範な心血管疾患を検出して治療できるようにします。血管造影カテーテルは柔軟性のある細い管で、動脈（最も一般的なのは大腿動脈または橈骨動脈）を通して挿入され、画像技術を用いて目的の部位に向けられます。

血管造影カテーテルは主に診断およびインターベンショナル心臓病学で冠動脈、末梢、および脳血管造影に使用されます。これらのカテーテルは、血管形成術、ステント留置術、塞栓術などの治療処置にも使用されます。イメージング技術の開発と、より柔軟で生体適合性が高く、ステアリング可能なカテーテルの開発により、血管造影カテーテルの将来は、より正確で侵襲の少ない手技が含まれるようになると思われます。心血管系疾患の世界的有病率の増加と画像誘導治療の増加により、血管造影カテーテルの需要は、おそらくロボット支援カテーテル治療とリアルタイム画像技術の増加の開発により、上昇し続けると予測されます。

カテーテル設計技術の進歩は血管造影カテーテル市場を促進するか？

カテーテル設計の進歩、特にマイクロカテーテルやステアラブルカテーテルなどの技術革新が血管造影カテーテル市場を後押ししています。これらの技術的進歩は、複雑な血管網においてより正確なナビゲーションを可能にし、血管造影治療の精度と安全性を向上させる。FDAが2020年に43の新しい心血管機器を承認したが、その多くはカテーテル技術を伴うものであり、これらの先端技術の利用が増加していることを示しています。

高齢者人口が血管造影カテーテル市場に拍車をかける可能性が高いです。世界人口の高齢化に伴い、冠動脈疾患やアテローム性動脈硬化症などの心血管障害の有病率が上昇し、これらは血管造影治療によって頻繁に発見・治療されます。国連によると、65歳以上の人口は2019年の7億300万人から2050年には15億人に倍増すると予測されています。このような高齢者人口の大幅な増加は、心血管検査や治療に対する需要を煽り、血管造影カテーテル市場の拡大を加速させると思われます。

手技に伴う高コストは血管造影カテーテル市場の成長を妨げるか？

血管造影カテーテルの市場成長には、血管造影手術の高コストが影響すると予想されます。こうした価格は、特にヘルスケア資源が限られている中低所得国において、こうした手技へのアクセスを制限し、総需要を低下させる可能性があります。病院やヘルスケア施設は、高度な血管造影装置やカテーテルに投資する際にもコスト上の制約に直面する可能性があります。先進国であっても、患者の出費は、特に保険適用が限定的なシステムにおいて、手技の遅延や縮小を招き、市場の成長を制限する可能性があります。

リスクや合併症は血管造影カテーテル市場の成長に影響を与える可能性があります。これらのカテーテルは重要な心血管処置に使用されるため、感染症、アレルギー反応、血管損傷、造影剤誘発性腎症などの危険性があれば、患者とヘルスケア関係者の双方に懸念が生じる可能性があります。規制当局の監視が強化され、医療従事者が別の診断法に目を向けるようになると、こうした危険性に対する認識が高まり、市場の拡大が制限される可能性があります。さらに、安全性への懸念が市場力学に影響を及ぼし、より安全なソリューションへの需要が高まる一方でコストが上昇し、普及が阻害される可能性もあります。

目次

第1章 血管造影カテーテルの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 血管造影カテーテルの世界市場展望

• 概要
• 市場力学
• 促進要因
• 抑制要因
• 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 血管造影カテーテルの世界市場：製品別

• スコアリングバルーンカテーテル
• 従来型カテーテル
• DEBカテーテル
• カッティングバルーンカテーテル

第6章 血管造影カテーテルの世界市場：用途別

• 造影センター
• 病院
• クリニック

第7章 血管造影カテーテルの世界市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• ドイツ
• 英国
• フランス
• その他欧州
• アジア太平洋
• 中国
• 日本
• インド
• その他アジア太平洋地域
• 世界のその他の地域
• ラテンアメリカ
• 中東・アフリカ

第8章 血管造影カテーテルの世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第9章 企業プロファイル

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

第10章 付録

• 関連レポート

Angiography Catheters Market Valuation - 2024-2031

The angiography catheters market is experiencing a surge in demand due to several factors. Primarily, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and stroke, has led to a greater need for diagnostic and interventional procedures. These catheters play a crucial role in visualizing blood vessels and performing minimally invasive treatments like angioplasty and stent placement. The market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of aroundUSD 2.42 Billion by 2031.

Advancements in catheter technology, including improved materials, smaller diameters, and enhanced imaging capabilities, have made them more effective and less invasive, further driving demand. The growing aging population, which is more susceptible to cardiovascular diseases, is contributing to the market's expansion. The rising demand for cost-effective and efficient angiography catheters is enabling the market to grow at aCAGR of 7.38% from 2024 to 2031.

Angiography Catheters Market: Definition/ Overview

Angiography catheters are specialized medical devices that inject contrast media into blood arteries to make them visible on X-ray imaging during angiography operations. These catheters aid in seeing the structure and function of the heart's arteries, veins, and chambers, allowing clinicians to detect and treat a wide range of cardiovascular diseases including blockages, aneurysms, and congenital anomalies. Angiography catheters are flexible, thin tubes that are put via an artery, most commonly the femoral or radial artery, and directed to the desired region using imaging techniques.

Angiography catheters are primarily used in diagnostic and interventional cardiology to perform coronary, peripheral, and cerebral angiograms. These catheters are also used in therapeutic procedures like angioplasty, stent implantation, and embolization. With developments in imaging technology and the development of more flexible, biocompatible, and steerable catheters, the future of angiography catheters will involve more precise and least invasive procedures. The growing global prevalence of cardiovascular illnesses, combined with an increase in image-guided therapies, predicts that demand for angiography catheters will continue to climb, possibly due to developments in robotic-assisted catheterization and increased real-time imaging technology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Advancement in Technology of Catheter Design Fuel the Angiography Catheters Market?

Advancements in catheter design, notably innovations such as micro-catheters and steerable catheters, are propelling the angiography catheter market. These technical advancements enable more precise navigation in complex vascular networks, improving the accuracy and safety of angiography treatments. The FDA's approval of 43 new cardiovascular devices in 2020, many of which involve catheter technology, demonstrates the rising use of these advanced technologies.

The elderly population is likely to fuel the angiography catheter market. As the world population ages, the prevalence of cardiovascular disorders such as coronary artery disease and atherosclerosis rises, which are frequently detected and treated via angiography treatments. According to the United Nations, the number of individuals aged 65 and more is predicted to double from 703 million in 2019 to 1.5 billion by 2050. This considerable increase in the older population will fuel demand for cardiovascular tests and therapies, accelerating the expansion of the angiography catheters market.

Will the High-Cost Associated with Procedures Hamper the Growth of the Angiography Catheters Market?

The high cost of angiography operations is anticipated to have an impact on market growth for angiography catheters. These prices can limit access to such procedures, particularly in low- and middle-income countries with limited healthcare resources, lowering total demand. Hospitals and healthcare facilities may also face cost constraints when investing in sophisticated angiography equipment and catheters. Patient expenses, even in industrialized countries, may result in delayed or curtailed procedures, especially in systems with limited insurance coverage, limiting market growth.

Risks and complications can have an impact on the growth of the angiography catheter market. These catheters are utilized in crucial cardiovascular procedures, and any dangers, including infections, allergic reactions, blood vessel damage, or contrast-induced nephropathy, might cause concern among both patients and healthcare personnel. Increased awareness of these dangers may restrict market expansion as regulatory scrutiny intensifies and healthcare professionals turn to alternate diagnostic methods. Furthermore, safety concerns may influence market dynamics, pushing demand for safer solutions while potentially increasing costs, and discouraging widespread use.

Category-Wise Acumens

Will the Integration of Drug-Eluting Technology Drive the Drug-Eluting Balloon Catheters Segments for the Angiography Catheters Market?

Drug-

eluting balloon catheter segments dominate the angiography catheters market. The integration of drug-eluting technology is projected to propel the drug-eluting balloon catheters sector of the angiography catheters market. Drug-eluting balloon catheters direct therapeutic substances to the target site, lowering restenosis and enhancing patient outcomes in vascular procedures. This technology, together with increased rates of cardiovascular disease and a shift toward minimally invasive procedures, is expected to increase demand and expand the market for these advanced catheters.

The prevalence of cardiovascular illnesses is projected to drive the expansion of the drug-eluting balloon (DEB) catheter segment in the angiography catheter market. As cardiovascular disorders such as coronary artery disease and peripheral artery disease become more common, owing to aging populations and lifestyle choices, there is a greater need for better treatment alternatives. DEB catheters, which release medicines to prevent arterial re-narrowing (restenosis) during angioplasty, are a targeted and successful treatment that reduces the need for stent insertion. This makes them an appealing alternative for healthcare professionals, accelerating their adoption in response to the growing burden of cardiovascular disease.

Will the High Volume of Patients Requiring Cardiovascular Procedures Accelerate the Hospital's Segment for the Angiography Catheters Market?

Hospital's segment fastest leading in the angiography catheters market. The large volume of patients requiring cardiovascular operations is expected to boost the angiography catheters market in the hospital segment. As the prevalence of cardiovascular illnesses rises worldwide, there is an increasing demand for diagnostic and interventional techniques that rely primarily on angiography catheters. These devices are critical for diagnosing and treating coronary artery disease and peripheral vascular disease. Furthermore, advances in catheter technology and increased healthcare investments in cardiovascular care are propelling this market forward, as hospitals strive to improve diagnostic accuracy and treatment efficacy.

The availability of advanced medical equipment and qualified workers is expected to drive the hospital segment's growth in the angiography catheter market. This expansion is being driven by the rising need for precise diagnostic and therapeutic treatments that necessitate high-quality angiography catheters. Advanced equipment improves the accuracy and efficiency of these treatments, while trained clinicians make the best use of the technology, resulting in better patient results. Furthermore, the increased prevalence of cardiovascular disorders, as well as the necessity for sophisticated imaging procedures to manage these conditions, are driving up demand for advanced angiography catheters in hospitals.

Country/Region-wise Acumens

Will Improvement in Health Infrastructure in North America Boost the Angiography Catheters Market?

North America is dominating in angiography catheters market thanks to its improved health infrastructure. The growing progress of healthcare infrastructure will drive the North American angiography catheters market. North America excels in this market due to its advanced healthcare infrastructure, large patient population, and high frequency of cardiovascular disorders. With cardiovascular disease expected to affect more than 40% of the US population by 2030, the demand for sophisticated diagnostic tools such as angiography catheters will increase. Furthermore, the strong presence of major industry players and ongoing advancements will drive market expansion in the region.

The North American market for angiography catheters is predicted to rise due to an aging population. According to the United States Census Bureau, the baby boomer group will account for 73 million of the senior population by 2030. Because cardiovascular disease risk rises with age, this demographic trend is projected to boost the demand for diagnostic equipment such as angiography catheters. As a result, North America's expanding elderly population will significantly drive market demand, as more individuals will need cardiovascular evaluations and treatments.

Will Increasing Awareness of Cardiovascular Health Lead the Asia Pacific's Angiography Catheters Market?

Asia Pacific is rapidly growing in the angiography catheters market owing to its increased awareness of cardiovascular health. The increasing frequency of cardiovascular diseases (CVDs), which are the main cause of death worldwide, particularly in Asia, accounts for 35% of all deaths. As people become more conscious of their cardiovascular health, they seek diagnostic and interventional procedures, which increases the demand for angiography catheters. Furthermore, the region's aging population and expanding healthcare facilities drive up demand, positioning the market for significant development.

Government initiatives are propelling the Asia-Pacific angiography catheters market. Efforts to enhance healthcare access and affordability are driving market growth, as demonstrated in China, where coronary angiography operations increased by about 50% between 2015 and 2019, owing to rising healthcare costs and an aging population. Similarly, India's rising prevalence of cardiovascular illnesses, which is expected to exceed 103 million cases by 2030, and Japan's consistent increase in percutaneous coronary interventions (PCI) drive demand for angiography catheters, generating significant potential possibilities in the area.

Competitive Landscape

The angiography catheters market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include:

• Medtronic
• Boston Scientific Corporation
• Terumo Medical Corporation
• Merit Medical Systems
• AngioDynamics
• Cardinal Health
• Braun Melsungen AG
• Becton
• Dickinson and Company

Latest Developments

• In February 2022, Teleflex received Food and Drug Administration clearance for an expanded indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions.
• In October 2022, The HELIOSTAR Balloon Ablation Catheter is indicated for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria beginning when combined with a suitable multi-channel RF generator.
• In July 2021, Philips announced the first minimally-invasive heart procedure using its real-time 3D intracardiac echocardiography catheter

TABLE OF CONTENTS

1. Introduction of Global Angiography Catheters Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Angiography Catheters Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Angiography Catheters Market, By Product

• Scoring Balloon Catheters
• Conventional Catheters
• DEB Catheters
• Cutting Balloon Catheters

6. Global Angiography Catheters Market, By Application

• ASCs
• Hospitals
• Clinics

7. Global Angiography Catheters Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Angiography Catheters Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

10. Appendix

• Related Reports